

The Power of Precision
Native mass spectrometry (or native mode analysis) has always been very interesting, but it has also become very useful. Analyzing non-covalent species is required for new and emerging classes of protein therapeutics, such as bispecific and multi-specific antibodies. It is also needed to identify size variants of conventional monoclonal antibodies (mAbs). SCIEX has answered the call for high-resolution, native mass spectrometry with our Turbo V™ Ion Source design and ion optics. SCIEX technology is ideally suited to efficient and gentle desolvation of non-covalent complexes, which enables aggregate analysis, stoichiometry determination and fragment-based drug design.
Witness higher level interactions for a higher level of understanding
Native mass spectrometry enables better development of both current and next generation biologic therapies. Native mass spectrometry provides accurate information on higher level structure, aggregate identity, non-covalent binding and stoichiometry of binding. SCIEX native mass spectrometry solutions enable scientists to achieve dalton-specific confirmations of both protein–protein and protein–ligand non-covalent interactions.
High-speed, accurate mass analysis with a compact and streamlined QTOF system and the renowned Turbo V™ Ion Source
Built for large-scale quantification and flexible use. Achieve sensitive and robust quantification using dedicated low flow source technology
Switching to high-sensitivity, low-flow analyses couldn’t be easier.
With new titanium hardware to minimize priming, three particle platforms for optimal versatility and eight particle chemistries to maximize selectivity and sensitivity.
Sean McCarthy, Ph.D. provides insights into why native mass spectrometry is an important and emerging in biopharma analysis.
Native LC-MS Analysis of an Intact Cysteine-Linked Antibody-Drug-Conjugate
Native Mass Spectrometry using the X500B QTOF System for Fragment-Based Screening
Native Analysis of Intact Monoclonal Antibody Aggregates Using the TripleTOF® 6600 System
Characterization of Intact Monoclonal Antibodies under Native and Reverse Phase Conditions Using High Resolution Mass Spectrometry